$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs
08:51am, Monday, 19'th May 2025
Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.
3 Magnificent Stocks That Are Passive Income Machines
06:40am, Saturday, 17'th May 2025
Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.
Abbott (ABT) Up 1.8% Since Last Earnings Report: Can It Continue?
12:30pm, Friday, 16'th May 2025
Abbott (ABT) reported earnings 30 days ago. What's next for the stock?
Abbott India's quarterly profit climbs 28% on strong demand
10:12am, Thursday, 15'th May 2025
Drugmaker Abbott India reported a 28% rise in fourth-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.
New data reveal a 78% reduction in cardiovascular disease-related hospitalizations for people living with Type 1 diabetes with prior severe low blood sugar episodes.1 This significant decrease is link
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?
04:00pm, Wednesday, 07'th May 2025
Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Wednesday, 07'th May 2025
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know
04:00pm, Monday, 05'th May 2025
Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure.
Abbott Labs CEO on federal health care spending, investing in healthy people and weight loss drugs
03:10pm, Monday, 05'th May 2025
Robert Ford, Abbott Labs CEO, joins 'Power Lunch' to discuss government spending on health care and technological investments.
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?
08:20am, Saturday, 03'rd May 2025
Investing in excellent dividend stocks can be a great strategy to mitigate risk and boost long-term returns. Companies that can dispense regular payouts to their shareholders -- especially those that
US judge allows testimony that Abbott and Mead Johnson preterm baby formula caused deadly disease
05:59pm, Friday, 02'nd May 2025
A federal judge on Friday said she will allow expert testimony that formula made by Abbott Laboratories and Reckitt Benckiser subsidiary Mead Johnson for premature babies can cause a fatal intestinal
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
09:00am, Thursday, 01'st May 2025
The test, run on Abbott's portable i-STAT ® Alinity® hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concu
Best Dividend Aristocrats For May 2025
08:07pm, Tuesday, 29'th Apr 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Ed
Collaboration brings together FreeStyle Libre® Systems, the world's leading continuous glucose monitoring technology (CGM)1 with Epic, a healthcare software company, to streamline access to CGM data
PBH or ABT: Which Is the Better Value Stock Right Now?
12:45pm, Monday, 28'th Apr 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best optio
Sign In
Buy ABT